High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

  • S Chow (Contributor)
  • V Galvis (Contributor)
  • M Pillai (Contributor)
  • R Leach (Contributor)
  • E Keene (Contributor)
  • A Spencer-Shaw (Contributor)
  • A Shablak (Contributor)
  • J Shanks (Contributor)
  • T Liptrot (Contributor)
  • F Thistlethwaite (Contributor)
  • Robert Hawkins (Contributor)

Dataset

Search results